Holen Sie sich die Stockscreener-App
2.50
0.00%
0.00
Schlusskurs vom Vortag:
$2.50
Offen:
$2.26
24-Stunden-Volumen:
71,138
Relative Volume:
0.01
Marktkapitalisierung:
$2.02M
Einnahmen:
$232.00K
Nettoeinkommen (Verlust:
$-12.13M
KGV:
-0.2795
EPS:
-8.9454
Netto-Cashflow:
$-10.29M
1W Leistung:
-19.87%
1M Leistung:
+775.96%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$2.22
$2.40
1-Wochen-Bereich:
$2.22
$3.21
52-Wochen-Spanne:
$0.1116
$3.87
Valion Bio Inc Stock (VBIO) Company Profile
Firmenname
Valion Bio Inc
Sektor
Branche
Telefon
(888)276-6888
Adresse
1305 E. HOUSTON STREET, SAN ANTONIO
Compare VBIO vs PSNYW, GOODO, SHMD, CHAD, DWLD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 0.00 | 0 | 0 | 0 | 0 | 0.00 | |
PSNYW
Polestar Automotive Holding Uk
|
4.29 | 773.76M | 2.07B | -1.42B | -1.37B | -0.6765 |
GOODO
Gladstone Commercial Corporation
|
20.35 | 372.90M | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
3.33 | 220.96M | 52.15M | -21.46M | 0 | -0.4675 |
CHAD
Direxion Daily CSI 300 China A
|
7.8954 | 197.39M | 0 | 0 | 0 | 0.00 |
DWLD
Davis Select Worldwide ETF
|
46.62 | 0 | 0 | 0 | 0 | 0.00 |
Valion Bio Inc Aktie (VBIO) Neueste Nachrichten
Investor group in Valion Bio (VBIO) shifts to passive stake - Stock Titan
Valion Bio Announces Changes to Management and Board of Directors - ACCESS Newswire
3i's $16.3M note in Valion Bio (VBIO) carries a 9.99% cap - Stock Titan
Aberdeen Income Credit Strategies Fund (ACP-PA) Peer Comparison – Compare with Others - Value Research
3i invests $7.7M in Valion Bio (VBIO) via preferreds and warrants - Stock Titan
Valion Bio (VBIO) Stock Analysis Report | Financials & Insights - Benzinga
Valion Bio appoints CFO Lisa Wolf as president, COO - TipRanks
Valion Bio's Ownership Structure Based on 32,140,634 Shares Outstanding (NASDAQ: VBIO) - Kalkine Media
Valion Bio Expands Lisa Wolf’s Role, Adds Two Board Directors - citybiz
Valion Bio names Lisa Wolf president and COO, adds directors - Investing.com
Valion Bio names Lisa Wolf president and COO, adds directors By Investing.com - Investing.com Nigeria
Valion Bio raises capital via new preferred financing - TipRanks
Valion Bio appoints Jared Malbin and Thomas Jensen to its board - TradingView
Valion Bio, Inc. Common Stock (VBIO) Financials 2026Income Statement and Balance Sheet - MarketBeat
Valion Bio Inc (VBIO) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
3i group holds sub-10% Valion Bio (VBIO) stake with warrants, note - Stock Titan
Valion Bio Inc (VBIO) Peer Comparison – Compare with Others - Value Research
Valion Bio Announces 1-for-25 Reverse Stock Split to Regain Nasdaq Compliance - Minichart
Valion Bio announces 1-for-25 reverse stock split By Investing.com - Investing.com Nigeria
Valion Bio Announces Reverse Stock Split - ACCESS Newswire
News by ACCESS Newswire on TradingView, 2026-08-27 - TradingView
Valion Bio (VBIO) holder nears 10% after big preferred swap - Stock Titan
Valion Bio, Inc. SEC Filing (Aug 24, 2026) - Stock Titan
3i injects cash into Valion Bio (VBIO) under tight ownership cap - Stock Titan
Valion Bio Terminates CEO in Change of Corporate Leadership - Minichart
Form 8K Valion Bio Inc For: 17 August By Investing.com - Investing.com Nigeria
Valion Bio appoints new COO, terminates CEO, and announces funding agreements - Investing.com Canada
Valion Bio Secures New Series B Preferred Financing - TipRanks
Valion Bio, Inc. terminates Michael K. Handley as CEO, Effective August 16, 2026 - marketscreener.com
Valion Bio Cash Plunges to $2.1M, Flags Going-Concern Risk - Minichart
Valion Bio (VBIO) investor group reports 1.74M shares, capped at 9.9% stake - Stock Titan
Valion Bio (OTC: VBIO) faces going concern risk and Nasdaq bid price warning - Stock Titan
Valion Bio, Inc. Q2 2026: Net loss $7.1M, EPS $(2.17) — 10-Q Summary - TradingView
Valion Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Entolimod Could Receive Its First National Registration in Ukraine - Stock Titan
Valion Bio, Inc. SEC Filing (Aug 13, 2026) - Stock Titan
Ukraine's Ministry Of Health Advances Entolimod Review Into Technical Assessment Phase - ACCESS Newswire
Valion Bio, Inc. (VBIO) Stock Price, News, Quote & History - Yahoo! Finance Canada
Valion Bio Inc. (VBIO) Profile, Company FAQs & Facts, Industry, Sector, Employee Strength - Stocktwits
Valion Bio Advances Government-Funded Entolimod Radiation Injury Studies With Data Expected in Early Fall - Yahoo Finance
Valion Bio begins safety study for radiation injury drug By Investing.com - Investing.com India
Valion Bio begins safety study for radiation injury drug - Investing.com
News by ACCESS Newswire on TradingView, 2026-08-12 - TradingView
Valion Bio Plans Mouse Study After Lethal Radiation Exposure - Stock Titan
Valion Bio, Inc. (OTC: VBIO) investors file 13D/A and outline $9M preferred stock plan - Stock Titan
Valion Bio, Inc.Common stock (Nasdaq:VBIO) Stock Quote - FinancialContent
Insiders Who Sold Valion Bio Missed Out On 19% Stock Increase - webull.com
Valion Bio Enters Securities Purchase Agreement With Avenue, Issues Preferred for $750,000 Milestone - tradingview.com
3i, LP Issues Letter to Valion Bio, Inc - marketscreener.com
Valion Bio Inc (NASDAQ: VBIO) Share Price, VBIO Stock News, VBIO Share Price & Updates - Kalkine
Murchinson Ltd. Acquires 440,242 Shares in Valion Bio Inc. - GuruFocus
Finanzdaten der Valion Bio Inc-Aktie (VBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Valion Bio Inc-Aktie (VBIO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Valauri Christina Rizopoulos | Director |
Apr 01 '26 |
Buy |
0.95 |
19,000 |
18,008 |
19,000 |
0.63%
3.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):